Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Drug Induced Liver Disease
How do you counsel patients on the use and risks of alternative medications and supplements given how prevalent and easily accessible they are to the average person?
Related Questions
When do you pursue liver biopsy for assessment of DILI?
How would you approach the management of drug-induced autoimmune hepatitis compared to non-drug-induced autoimmune hepatitis?
What are your biggest takeaways from the MASH-TAG 2025 conference?
How do you approach a patient who has incidentally found liver and renal cysts?
What is your approach to the management of anti-pruritic therapies in patients with cholestatic liver disease?
How do you approach the use of viscoelastic assays (ex: TEG, ROTEM) in patients with identified coagulopathy in the peri-procedural period?
How do you approach a patient with discordant Fibroscan and serologic testing for fibrosis?
How do you approach fertility/family planning and counseling in patients with end-stage liver disease?
How do you incorporate addiction medicine and counseling into your treatment plan for patients with alcohol associated liver disease?
Do you always consider ADPCKD or ARPCKD in a patient who is incidentally found to have liver and renal cysts?
